# Portfolio Analysis Report

**Client:** CLIENT-123 | **Date:** 2025-11-14
**Portfolio Value:** $12 | **Benchmark:** SPY

---

## Executive Summary

Portfolio demonstrates strong performance with moderate risk. Minor adjustments recommended to improve diversification.

**Overall Suitability:** 82/100 - Highly Suitable

---

## Risk Analysis

| Metric | Value | Rating |
|--------|-------|--------|
| Volatility | 15.5% | Medium |
| Beta | 1.05 | Medium |
| VaR 95% | -8.2% | Medium |
| Concentration | 35/100 | Medium |

**Risk Rating:** MEDIUM

**Concerns:**
- High tech sector exposure
- Limited international diversification

**Recommendations:**
- Consider adding bonds
- Increase international allocation

---

## Compliance Review

**Status:** PASS

**Checks Performed:**
- Suitability check
- Concentration limits
- Regulatory compliance

**Violations:** None

**Required Disclosures:**
- Past performance does not guarantee future results

---

## Performance Analysis

| Metric | Value |
|--------|-------|
| Total Return | 12.5% |
| Benchmark Return | 10.2% |
| Excess Return | +2.3% |
| Sharpe Ratio | 1.45 |
| Alpha | +1.8% |
| Percentile Rank | 72th |

**Top Performers:**
- AAPL: +25.3%
- MSFT: +18.7%

**Sector Attribution:**
| Sector | Contribution |
|--------|-------------|
| Technology | +5.2% |
| Healthcare | +3.1% |
| Financials | +2.2% |

---

## Suitability Analysis

**Overall Score:** 82/100 - Highly Suitable

**Component Scores:**
- Risk Fit: 85/100
- Compliance Fit: 90/100
- Performance Fit: 78/100
- Time Horizon Fit: 77/100

**Explanation:**
Portfolio aligns well with client risk tolerance and investment objectives. Risk level is appropriate for moderate investor with 10+ year time horizon.

---

## Recommendations

1. Rebalance to reduce tech concentration to 30%
2. Add 10% international exposure
3. Consider 15% bond allocation

---

## Action Items

- Schedule 6-month review
- Consider tax-loss harvesting opportunities

---

*Report generated on 2025-11-14 09:40:32*